Filing Details
- Accession Number:
- 0000784199-21-000121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-04 13:00:00
- Reporting Period:
- 2021-04-30
- Accepted Time:
- 2021-05-04 16:08:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1112830 | Ashley David Lee | Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | Executive Vp, Coo & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-30 | 6,800 | $11.00 | 299,485 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-30 | 6,800 | $30.00 | 292,685 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | StockOption(Right to Buy) | Disposition | 2021-04-30 | 6,800 | $11.00 | 6,800 | $11.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-02-19 | 2022-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,500 | Indirect | *Indirect shares owned by spouse (5000) and minor children (1,500) |
Footnotes
- The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021
- Reflects the price of $30 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016
Billionaire Hedge Funds
